Evidence map›Paper›PMID 27350833›Full record

ReviewPrzeglad gastroenterologiczny2016

A contemporary approach to body mass regulation mechanisms.

Andrzej Nowak, Elżbieta Czkwianianc

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Przeglad gastroenterologiczny, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03968224 (Effectiveness of the Treatment With Dapagliflozin and Metformin Compared to Metformin Monotherapy for Weight Loss on Diabetic and Prediabetic Patients With Obesity Class III), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03968224 phase2 / phase3completedstarted 2018, after this paper: background citation

Effectiveness of the Treatment With Dapagliflozin and Metformin Compared to Metformin Monotherapy for Weight Loss on Diabetic and Prediabetic Patients With Obesity Class III

Ran2018Enrolled160Registered outcomes7Posted comparisons4ConditionsDiabetes Mellitus, Type 2, Obesity, Morbid, PrediabetesArmsDapagliflozin/Metformin, Metformin
Open the trial in the graph
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Andrzej NowakDepartment of Gastroenterology, Allergology and Pediatrics, Polish Mother's Memorial Hospital Research Institute, Lodz, Poland.
Elżbieta CzkwianiancDepartment of Gastroenterology, Allergology and Pediatrics, Polish Mother's Memorial Hospital Research Institute, Lodz, Poland.
Polish Mother’s Memorial Hospital Research Institute · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, a lot of factors and mechanisms regulating body mass have been discovered, although there are still many unknowns. Their effect on the development of many diseases related to nutritional disorders (obesity, anorexia, celiac disease, inflammatory bowel disease) means that the understanding of these mechanisms will make it possible to determine new therapeutic goals and create new medicinal products. This is even more important because nowadays there is no effective medication to cure nutritional disorders. It is necessary to conduct further research to evaluate dependencies and relationships between particular hormones and to study newly discovered substances so that we could progress towards achieving the overall objectives while keeping the ultimate goals in mind.

Indexed as

ghrelinneuropeptide Yorexigenic factors

Identifiers

PMID27350833
PMCPMC4916241
OpenAlexW2395007385

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.